CD19 Targeted Low-Dose Rituximab Is Effective in the...

  • Main
  • 2016 / 9
  • CD19 Targeted Low-Dose Rituximab Is Effective in the...

CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy

Ramachandran, Raja, Yadav, Ashok K., Kumar, Vinod, Gupta, Krishan L., Kohli, Harbir S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Kidney International Reports
DOI:
10.1016/j.ekir.2016.08.019
Date:
September, 2016
File:
PDF, 138 KB
english, 2016
Conversion to is in progress
Conversion to is failed